SCHEMBL21602832

SCHEMBL21602832

CCC(=O)N1Cc2ccccc2-c2c(nnn2I)-c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 2/20 0.49
ADORA1 P30542 2/20 0.38
CES1 P23141 1/20 0.35
NOTUM Q6P988 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
HSD17B3 P37058 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TSHR P16473 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015342 0.88 NOTUM (0.47) HTTSMN1; SMN2KDM4ENOTUMHSD17B3
SCHEMBL16204548 0.87 SMN1; SMN2 (0.50) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL17903051 0.86 SMN1; SMN2 (0.49) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL23280914 0.85 KDM4E (0.48) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL25963258 0.84 NOTUM (0.35) HTTSMN1; SMN2KDM4ENOTUMHSD17B3
SCHEMBL15948103 0.83 HSD17B3 (0.49) HTTSMN1; SMN2KDM4ENOTUMHSD17B3
SCHEMBL15958791 0.83 KDM4E (0.50) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL14315405 0.82 KDM4E (0.49) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL19387290 0.81 KDM4E (0.48) HTTSMN1; SMN2KDM4EADORA1CES1
SCHEMBL22472682 0.80 KDM4E (0.47) HTTSMN1; SMN2KDM4EADORA1CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242691-A1 PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF 圣多利康制药责任有限公司 2019-12-26 WO disclosed